Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
---
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Meet the Cure Team Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Cure Symposium Calendar

Carla Gauss, Ph.D.

Carla Gauss, Ph.D., is a Senior Director, Medicinal Chemistry, Deerfield Discovery and Development, and joined the Firm in 2022. Prior to Deerfield, Dr. Gauss was a Senior Application Scientist, Medicinal Chemistry at Nanome. Before Nanome, she served as a Research Investigator at Cold Spring Harbor Laboratory, where she worked for 11 years. Before this, Dr. Gauss held various positions as a scientist at Progenics Pharmaceuticals, Cara Therapeutics, Memory Pharmaceuticals and Exelixis. Dr. Gauss holds a B.S. in Chemistry and a B.A. in Biology from University of Virginia and a Ph.D. in Organic Chemistry from University of California at Irvine.

Eric Schiffhauer, Ph.D.

Eric Schiffhauer, Ph.D., is an Associate Director, Academic Outreach, Deerfield Discovery and Development, and joined the Firm in 2022. Prior to Deerfield, Dr. Schiffhauer spent three years at Northwestern University, most recently as a Scientific Collaboration Director. Before Northwestern, he held positions at Adi Family Office and Johns Hopkins Technology Ventures. Dr. Schiffhauer holds a B.S. in Biology from George Mason University and a Ph.D. in Biochemistry, Cellular and Molecular Biology from Johns Hopkins University.

Carrie Wei, Ph.D.

Carrie Wei, Ph.D., is a Director, Drug Metabolism and Pharmacokinetics, Deerfield Discovery and Development, and joined the Firm in 2022.  Prior to Deerfield, Dr. Wei spent three years at Biogen as an Associate Director and Team Leader, Drug Metabolism and Pharmacokinetics.  Before Biogen, Dr. Wei was a Group Leader and Principal Scientist, Drug Metabolism and Pharmacokinetics at Vertex Pharmaceuticals for three years and held various other roles of increasing responsibilities at Bristol Myers Squibb and Pfizer.  Dr. Wei holds a B.S. in Biological Sciences from Wuhan University, an M.S. in Biological Sciences and Neuroscience from Purdue University, and a Ph.D. in Pharmacology from University of Pennsylvania.

Kevin Goncalves

Kevin Goncalves, Ph.D., is a Director, In Vitro Pharmacology, Deerfield Discovery and Development, and joined the Firm in 2022.  Prior to Deerfield, Dr. Goncalves spent nearly six years at Magenta Therapeutics in roles of increasing seniority, most recently as Director, Translational Sciences.  He holds a B.S. in Biology from Fairfield University and a Ph.D. in Cellular and Molecular Physiology from Tufts University.

Oleg Laptenko

Oleg Laptenko, Ph.D., is a Principal Scientist, Discovery Biology, Deerfield Discovery and Development and joined the Firm in 2022.  Prior to Deerfield, Dr. Laptenko worked as a Scientist at a gene therapy start up for two years and at Inzen Therapeutics for two years.  Before these roles, Dr. Laptenko spent 13 years at Columbia University in Dr. Carol Prives’ laboratory working as a Post-Doctoral Scientist and then as an Associate Research Scientist.  He holds an M.S. in Biochemistry from Kharkov National University in Ukraine and a Ph.D. in Biochemistry from Kharkov National University & SUNY Downstate.

Sneha Mathew

Sneha Mathew is an Associate Director, Project Management, Deerfield Discovery and Development and joined the Firm in 2022.  Prior to Deerfield, Ms. Mathew was Director of Project Management at Seed Therapeutics for two years.  Before this role, she was employed as a Scientist for Adlai Nortye USA and as a Principal Research Associate for Inzen Therapeutics.  Prior to these positions, Ms. Mathew worked at Eli Lilly and Company for almost 11 years as a Research Scientist and Principal Research Associate.  Ms. Mathew holds a B.A. and an M.A. in Biology with a specialization in Biotechnology from The City University of New York’s Hunter College.

JoAnn Scatina, Ph.D.

JoAnn Scatina, Ph.D., is a Scientific Fellow, Deerfield Discovery and Development, and joined the Firm in 2022. Prior to this role, Dr. Scatina spent three years as a Preclinical Consultant to Deerfield. Before this, she was Senior Vice President, Preclinical Development at Lycera Pharmaceuticals for eight years. Prior to Lycera, Dr. Scatina spent twenty-six years at Wyeth in roles of increasing responsibility, with her most recent position being Vice President, Drug Metabolism. Dr. Scatina holds a B.A. in Microbiology from Rutgers University and a Ph.D. in Pharmacology and Toxicology from University of Medicine and Dentistry of New Jersey.

Alessandro Mora, Ph.D.

Alessandro Mora, Ph.D. is a Director, Biopharmaceutical Development, Deerfield Discovery and Development, and joined the Firm in 2022. Prior to Deerfield, Dr. Mora spent two years at Kadmon, a Sanofi Company where he was Director, CMC Biologics. Before Kadmon, Dr. Mora spent three years at Jounce Therapeutics as a Principal Scientist, CMC Operations, Product Development and Technical Operations, and seven years at AbbVie / Abbott Bioresearch Center as a Scientist, Cell Line Development, Process Sciences. Dr. Mora holds a B.S and an M.Sc. in Biotechnology from Sapienza University in Rome, Italy, and a Ph.D. in Biomedical Engineering and Biotechnology from University of Massachusetts Lowell.

Tian Yang, Ph.D.

Tian Yang, Ph.D., is a Vice President, Preclinical Development, Deerfield Discovery and Development, and joined the Firm in 2022. Prior to Deerfield, Dr. Yang spent ten years at the Global Alliance for TB Drug Development with responsibility for toxicology, as well as drug metabolism and pharmacokinetics (DMPK). Before TB Alliance, he worked as Head of Enzymology and Drug Metabolism at Hoffmann-La Roche, and held various other roles at Bristol Myers Squibb and Dupont Pharmaceutical. He began his career at the National Cancer Institute, researching carcinogen-activating P450s. Dr. Yang holds a B.S. in Pharmacy from Lanzhou University, and a Ph.D. in Pharmacology and Toxicology from Peking Union Medical College. Dr. Yang is a Diplomate of the America Board of Toxicology (DABT).

Eyal Vardy, Ph.D.

Eyal Vardy, Ph.D., is a Director, In Vitro Pharmacology, Deerfield Discovery and Development, and joined the Firm in 2021.  Prior to Deerfield, Dr. Vardy was an in-vitro scientist at Kallyope for four years. Before Kallyope, he was Senior Scientist in Pharmacology at Merck for three years.  Dr. Vardy holds a Ph.D in Biological Chemistry, as well as an M.Sc. and a B.Sc. in Biochemistry and Food Science from the Hebrew University in Jerusalem.